Rapid CRP tests reduce antibiotic misuse & development of antibiotic resistance
August 5th 2016Researchers from the Oxford University Clinical Research Unit have found that a 5-minute CRP test can assist in the ongoing fight against antibiotic resistance by reducing antibiotic misuse for respiratory infections.
New RNA Vaccines May Reduce Disease Outbreak Response Time
August 3rd 2016Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.
Increasing Zika Transmission in Puerto Rico and Florida Prompts Additional CDC Funding
August 2nd 2016The rapid spread of Zika throughout Puerto Rico coupled with the introduction of active transmission in Florida has prompted the Centers for Disease Control and Prevention (CDC) to award millions in Zika funding to US states and territories.
World's Largest Partnership Formed to Fight Antimicrobial Resistance
August 1st 2016The world’s largest public-private partnership has been formed in a collective effort to battle antimicrobial resistance through a global project, CARB-X, which will be comprised of expert product developers who will research and develop new antimicrobial products.
MRSA-eliminating Bacteria Found Within the Human Body
July 29th 2016A new study conducted by Andreas Peschel, PhD, and colleagues at the University of Tuebingen in Germany, has shown that lugdunin, a bacteria naturally produced by the human body, can be used as an antibiotic that can eliminate Methicillin-Resistant Staphylococcus aureus (MRSA).
Yellow Fever Vaccine Enters Clinical Trial
July 29th 2016In response to the growing outbreak, and the escalating need for a vaccine that can be used in infants, those who are immunocompromised, and other populations in whom currently available vaccines are not to be administered, the NIAID has entered a vaccine manufactured by Bavarian Nordic into Phase I trials.
Have Researchers Finally Found the Key to a Universal Influenza Vaccine?
July 28th 2016Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI) believe they have found the key to developing a universal vaccine for influenza.
HIV Vaccine Targets Subtype Circulating in Southern Africa
July 27th 2016Recently, there have been several breakthroughs in the fight against HIV, including trials that would test an HIV vaccine targeting a specific subtype of the virus, and several prevention methods that would reduce the risk of infection transmission.